{"slug":"edwards-lifesciences","name":"에드워즈 라이프사이언스","name_en":"Edwards Lifesciences","ticker":"EW","updated_at":"2026-07-11T10:20:08.175+00:00","canonical":"https://valuechain.wiki/edwards-lifesciences","kicker":"헬스케어 · S&P 500","kicker_en":"Health Care · S&P 500","lead":"심장판막과 중환자 모니터링 장비를 개발하는 의료기기 기업으로 경피적 판막치환술 분야를 선도한다. S&P 500 구성종목. 섹터: 헬스케어(Health Care Equipment). 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A medical device company developing heart valves and critical care monitoring, leading in transcatheter heart valve replacement. S&P 500 constituent. Sector: Health Care (Health Care Equipment). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"경피적 판막(TAVR)"},{"name":"경도관 승모·삼첨판(TMTT)"},{"name":"외과 구조 심장"}],"total":"약 $5.4B (FY2024)"},"segments_en":{"parts":[{"name":"TAVR"},{"name":"TMTT"},{"name":"Surgical Structural Heart"}],"total":"~$5.4B (FY2024)"},"returns_yearly":{"2021":42,"2022":-42.4,"2023":2.2,"2024":-2.9,"2025":15.2,"2026":8.2},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}